| Literature DB >> 27199475 |
Jeremy D Keenan1, Ida Sahlu2, Lesley McGee3, Vicky Cevallos4, Jorge E Vidal2, Sopio Chochua5, Paulina Hawkins5, Teshome Gebre6, Zerihun Tadesse6, Paul M Emerson7, Bruce D Gaynor1, Thomas M Lietman1, Keith P Klugman2.
Abstract
Twenty-four Ethiopian communities were randomized to receive either (1) quarterly mass azithromycin distributions for trachoma for 1 year or (2) delayed treatment. Nasopharyngeal swabs collected from separate cross-sectional population-based samples of children were processed for Streptococcus pneumoniae Mass azithromycin did not significantly alter the pneumococcal serotype distribution, and hence it would not be expected to alter vaccine coverage.Entities:
Keywords: Africa; Streptococcus pneumoniae; pneumococcal vaccines; serotype
Mesh:
Substances:
Year: 2015 PMID: 27199475 PMCID: PMC5407126 DOI: 10.1093/jpids/piu143
Source DB: PubMed Journal: J Pediatric Infect Dis Soc ISSN: 2048-7193 Impact factor: 3.164